Interplay between the Lung Microbiome, Pulmonary Immunity and Viral Reservoirs in People Living with HIV under Antiretroviral Therapy.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
29 10 2022
Historique:
received: 18 09 2022
revised: 19 10 2022
accepted: 27 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Pulmonary dysbiosis may predispose people living with HIV (PLWH) to chronic lung disease. Herein, we assessed whether intrapulmonary HIV reservoir size and immune disruption are associated with reduced bacterial lung diversity in PLWH. Bacterial DNA was extracted and PCR-amplified from cell-free bronchoalveolar lavage (BAL) fluid from 28 PLWH and 9 HIV-negative controls. Amplicon sequence variant (ASV) relative abundances and taxonomic identities were analyzed using joint species distribution modeling. HIV-DNA was quantified from blood and pulmonary CD4+ T-cells using ultra-sensitive qPCR. Immunophenotyping of BAL T-cells was performed using flow cytometry. Lung microbiome diversity was lower in smokers than non-smokers and microbiome composition was more variable in PLWH than HIV-negative individuals. Frequencies of effector memory BAL CD4+ and CD8+ T-cells positively correlated with abundance of several bacterial families while frequencies of BAL activated CD4+ T-cells negatively correlated with abundance of most lung bacterial families. Higher HIV-DNA levels in blood, but not in BAL, as well as frequencies of senescent CD4+ T-cells were associated with reduced bacterial diversity. These findings suggest that HIV infection may weaken the relationship between the lung microbiome and smoking status. Viral reservoir and immune activation levels may impact the lung microbiome, predisposing PLWH to pulmonary comorbidities.

Identifiants

pubmed: 36366495
pii: v14112395
doi: 10.3390/v14112395
pmc: PMC9693210
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : 153082
Pays : Canada

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Microbiome. 2022 Apr 11;10(1):59
pubmed: 35410461
Front Immunol. 2022 Jan 04;12:808722
pubmed: 35058937
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
J Virol. 2019 Nov 26;93(24):
pubmed: 31578289
PLoS Pathog. 2014 Jul 24;10(7):e1004262
pubmed: 25058515
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1188-1198
pubmed: 29864375
Immunity. 2021 Jul 13;54(7):1377-1391
pubmed: 34260886
J Vis Exp. 2019 Jun 23;(148):
pubmed: 31282892
Cell Microbiol. 2014 Jul;16(7):1024-33
pubmed: 24798552
J Infect Dis. 2013 Jul;208(1):50-6
pubmed: 23089590
Oncotarget. 2017 Jan 3;8(1):268-284
pubmed: 27902485
Top Antivir Med. 2012 Aug-Sep;20(3):101-5
pubmed: 22954610
J Clin Invest. 2021 Nov 15;131(22):
pubmed: 34473646
Respir Med. 2011 Nov;105(11):1655-61
pubmed: 21703841
J Infect Dis. 2008 Jan 1;197(1):126-33
pubmed: 18171295
J Infect Dis. 2014 Oct 15;210(8):1248-59
pubmed: 24795473
Am J Respir Crit Care Med. 2019 May 1;199(9):1127-1138
pubmed: 30789747
PLoS One. 2016 Sep 12;11(9):e0161437
pubmed: 27618692
Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75
pubmed: 23491408
Curr HIV/AIDS Rep. 2016 Jun;13(3):140-8
pubmed: 27121734
Expert Rev Respir Med. 2011 Dec;5(6):809-21
pubmed: 22082166
Ecol Lett. 2006 Jun;9(6):683-93
pubmed: 16706913
Front Immunol. 2021 Jan 15;11:604591
pubmed: 33519813
Ecol Lett. 2017 May;20(5):561-576
pubmed: 28317296
Am J Respir Crit Care Med. 2019 Sep 1;200(5):556-564
pubmed: 30860857
EBioMedicine. 2021 Sep;71:103538
pubmed: 34425308
J Clin Microbiol. 2015 Jul;53(7):2022-9
pubmed: 25878338
J Virol. 2020 Nov 23;94(24):
pubmed: 32967958
AIDS Rev. 2016 Jul-Sep;18(3):138-144
pubmed: 27438573
Microb Ecol. 2001 Apr;41(3):252-263
pubmed: 11391463
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
J Transl Med. 2019 Jul 15;17(1):225
pubmed: 31307469
Respir Res. 2018 Jul 27;19(1):140
pubmed: 30053882
Allergy. 2015 Feb;70(2):241-4
pubmed: 25413686
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
J Crohns Colitis. 2016 Apr;10(4):462-71
pubmed: 26660940
Front Aging Neurosci. 2017 Aug 29;9:281
pubmed: 28900395
Trends Immunol. 2021 Oct;42(10):846-848
pubmed: 34538594
Int J Chron Obstruct Pulmon Dis. 2014 Feb 21;9:229-38
pubmed: 24591822
AIDS. 2018 Oct 23;32(16):2279-2289
pubmed: 30102653
Immunity. 2022 Sep 13;55(9):1564-1580
pubmed: 36103853
Eur Respir J. 2018 Oct 25;52(4):
pubmed: 30093571
Nat Rev Microbiol. 2017 Jan;15(1):55-63
pubmed: 27694885
AIDS Care. 2020 Aug;32(8):979-983
pubmed: 32372653
Mech Ageing Dev. 2018 Oct;175:74-82
pubmed: 30055190
Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):612-6
pubmed: 10934095
Thorax. 2016 Sep;71(9):795-803
pubmed: 27146202
Lancet Respir Med. 2014 Jul;2(7):583-92
pubmed: 24831854
JAMA Netw Open. 2020 Jun 1;3(6):e207954
pubmed: 32539152
Curr Opin HIV AIDS. 2014 Jan;9(1):27-33
pubmed: 24247667
Respir Res. 2018 Sep 12;19(1):174
pubmed: 30208886
AIDS. 2019 Apr 1;33(5):793-804
pubmed: 30649052
PLoS Pathog. 2013 Feb;9(2):e1003174
pubmed: 23459007
Immunol Res. 2006;36(1-3):175-87
pubmed: 17337778
Nat Med. 2018 Apr 10;24(4):392-400
pubmed: 29634682
BMC Infect Dis. 2017 Dec 15;17(1):771
pubmed: 29246197
Nat Immunol. 2011 Jun;12(6):467-71
pubmed: 21739668
Am J Respir Crit Care Med. 2016 Jul 15;194(2):226-35
pubmed: 26835554

Auteurs

Zihui Wang (Z)

Département des Sciences Biologiques, Université du Québec à Montréal (UQAM), Montreal, QC H2X 1Y4, Canada.

Mohammad-Ali Jenabian (MA)

Département des Sciences Biologiques, Université du Québec à Montréal (UQAM), Montreal, QC H2X 1Y4, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3T 1J4, Canada.

Yulia Alexandrova (Y)

Département des Sciences Biologiques, Université du Québec à Montréal (UQAM), Montreal, QC H2X 1Y4, Canada.
Infectious Diseases and Immunity in Global Health Program, Research Institute of MUHC, Montreal, QC H4A 3J1, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.

Amélie Pagliuzza (A)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.

Ron Olivenstein (R)

Division of Respirology, MUHC, Montreal, QC H4A 3J1, Canada.

Suzanne Samarani (S)

Infectious Diseases and Immunity in Global Health Program, Research Institute of MUHC, Montreal, QC H4A 3J1, Canada.

Nicolas Chomont (N)

Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.

Steven W Kembel (SW)

Département des Sciences Biologiques, Université du Québec à Montréal (UQAM), Montreal, QC H2X 1Y4, Canada.

Cecilia T Costiniuk (CT)

Infectious Diseases and Immunity in Global Health Program, Research Institute of MUHC, Montreal, QC H4A 3J1, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.
Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH